Genotype may identify complication likelihood in sickle cell patients

Researchers have found a genotype that could help identify sickle cell disease (SCD) patients at greatest risk of common, yet severe, complications of SCD. The findings will be presented today at the American Physiological Society's Physiological and Pathophysiological Consequences of Sickle Cell Disease conference in Washington, D.C.

The chronic breakdown of (hemolysis) is a hallmark of SCD that increases during times of illness. Hemolysis leads to the release of hemoglobin—and a protein that binds with it called haptoglobin—that increase a patient's chances of developing (ACS). "ACS is defined broadly as increased respiratory effort, fever and a new radiodensity on chest X-ray. ACS is a significant cause of hospitalizations and death in children and adults with SCD," said the study's lead author, Shaina Willen, MD, of Vanderbilt University Medical Center in Tennessee. ACS is a common complication among SCD patients, affecting roughly 50 percent at least once in their lifetime.

HP1-1, HP1-2 and HP2-2 are the three genetic markers (genotypes) associated with haptoglobin. These genotypes predict how effective an individual's haptoglobin is at binding to and clearing away excess hemoglobin. The haptoglobin in people with the HP2-2 is not as effective in hemoglobin-binding, and HP2-2 has been linked to increased cellular (oxidative) damage. The research team hypothesized that patients with the HP2-2 genotype would be more susceptible to SCD-related complications including ACS, pain, stroke, retinal problems in the eyes, kidney disease and in the arteries of the lungs than patients with HP1-1 and HP1-2 genotypes.

The researchers tested 58 adults with SCD and found that 90 percent of those with the HP2-2 genotype had two or more SCD-related complications compared with 46.7 and 56.3 percent of those with the HP1-1 and HP1-2 genotypes, respectively. "Our study has identified an increased risk for the development of -related complications among adult participants with the HP2-2 genotype," Willen explained. "We have also found that children with the HP2-2 genotype are at increased risk for the development of pain episodes which is the most common cause of hospitalization in children and adults with SCD.

"This finding may identify both adults and children at risk for developing disease-related complications. The impact of the HP2-2 genotype on the ability of to scavenge products of hemolysis may provide therapeutic targets to investigate related to the oxidative effect of cell-free hemoglobin and the pathophysiology of complications in SCD."


Explore further

Stress, fear of pain may be cause of painful sickle cell episodes

Citation: Genotype may identify complication likelihood in sickle cell patients (2017, November 8) retrieved 4 June 2020 from https://medicalxpress.com/news/2017-11-genotype-complication-likelihood-sickle-cell.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments